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Polycomb group (PcG) proteins form multiprotein complexes, called Polycomb repressive complexes
(PRCs). PRC2 contains the PcG proteins EZH2, SUZ12, and EED and represses transcription through
methylation of lysine (K) 27 of histone H3 (H3). Suz12 is essential for PRC2 activity and its inactivation results
in early lethality of mouse embryos. Here, we demonstrate that Suz12/ mouse embryonic stem (ES) cells can
be established and expanded in tissue culture. The Suz12/ ES cells are characterized by global loss of H3K27
trimethylation (H3K27me3) and higher expression levels of differentiation-specific genes. Moreover, Suz12/
ES cells are impaired in proper differentiation, resulting in a lack of repression of ES cell markers as well as
activation of differentiation-specific genes. Finally, we demonstrate that the PcGs are actively recruited to
several genes during ES cell differentiation, which despite an increase in H3K27me3 levels is not always
sufficient to prevent transcriptional activation. In summary, we demonstrate that Suz12 is required for the
establishment of specific expression programs required for ES cell differentiation. Furthermore, we provide
evidence that PcGs have different mechanisms to regulate transcription during cellular differentiation.
The evolutionarily conserved Polycomb group (PcG) pro-
teins silence gene expression through the formation of multi-
protein complexes. The Polycomb repressive complex 2
(PRC2) contains the PcG proteins EZH2, EED, and SUZ12
and catalyzes the di- and trimethylation of lysine 27 of histone
H3 (H3K27me2 and H3K27me3, respectively) (8, 12, 19, 28). It
has been suggested that this modification serves as a “docking-
site” for the PRC1 complex and is required for maintaining
transcriptional repression (8, 19). The three PcG subunits of
PRC2 are all essential for embryonic development, and
Eed/, Ezh2/, and Suz12/ embryos all display severe
defects during gastrulation (15, 30, 32). SUZ12 is required for
PRC2 enzymatic activity, and Suz12/ embryos die around 7
days postcoitus (32). Loss of Suz12 leads to global loss of
H3K27me3 and to destabilization of Ezh2 (9, 32). These re-
sults demonstrate the critical role of Suz12 and PRC2 in reg-
ulating normal development and suggest that PRC2 controls
the expression of genes essential for early embryogenesis.
Embryonic stem (ES) cells isolated from the inner cell mass
(ICM) of preimplantation embryos (embryonic day 3.5 [E3.5])
are immortal and pluripotent. Their self-renewal requires leu-
kemia inhibitory factor (LIF)-dependent Stat3 activation as
well as the expression of ES cell-specific transcription factors
like Nanog and Oct4 (2). ES cells can give rise to all the
somatic cells of an organism and can be differentiated in vitro
to all cell types. They are therefore attractive as a tool to study
the molecular mechanisms that control cell fate decisions dur-
ing development.
Cell fate decisions start taking place before embryo implan-
tation, and ICM pluripotency is already lost during embryo
gastrulation (E7.5). Cell type specifications occur through
the establishment of specific gene expression programs that
require epigenetic-dependent transcriptional regulation (2).
Epigenetic control of transcription involves modifications of
both DNA and histones, and the factors that can “write” and
“read” these modifications play a critical role during develop-
ment (22).
Consistent with this model of development, it has not been
possible to establish Ezh2/ ES cell lines in tissue culture
(30). In contrast, Eed/ ES cells can be expanded in tissue
culture even though the cells lack global levels of H3K27 meth-
ylation (26). Eed/ ES cells have an increased expression of
differentiation-specific genes, and the cells “tend” to lose plu-
ripotency (4). The discrepancy between the phenotypes of
Ezh2/ and Eed/ ES cells suggests that Ezh2 could have
independent functions that do not involve H3K27 methylation.
In addition, recent reports have shown that both PRC2 and the
PRC1 are required to maintain the repression of differentia-
tion-specific genes in mouse and humans ES cells as well as in
human embryonic lung fibroblasts (TIG3) (4, 5, 21).
Here we describe the role of Suz12 in ES cell proliferation
and differentiation. We show that Suz12 is essential for
proper differentiation, but not proliferation, of ES cells.
Importantly, we show that different mechanisms of PcG
transcriptional regulation exist during development. This
involves active recruitment of PcGs to repress gene expres-
sion; however, we also demonstrate that increased levels of
H3K27me3 and PcG binding can also correlate with the
activation of gene expression.
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MATERIALS AND METHODS
Derivation of ES cells, culture, genotype, and sex determination. Blastocysts
were isolated from the uterus of superovulated pregnant Suz12/ female mice
at 3.5 days postcoitus in M16 medium (Sigma). Single blastocysts were cultured
on 0.5% gelatin-coated plates in Glasgow medium (Sigma) supplemented with
glutamine (Gibco), nonessential amino acids (Gibco), sodium pyruvate (Gibco),
50 M -mercaptoethanol–phosphate-buffered saline (PBS; Gibco), and 20%
ES-cell-tested fetal bovine serum (HyClone) in the presence of 2,000 U/ml of
LIF (ESGRO). ICM outgrowths were expanded and kept in culture in the same
basal medium with 10% fetal bovine serum and 1,000 U/ml of LIF. Genotyping
of single clones was performed as described previously (32). Sex was determined
by PCR using the following primers: Xist forward, 5-GCTTTGTTTCACTTTC
TCTGGTGC-3; Xist reverse, 5-ATTCTGGACCTATTGGGAAG-GGGC-3;
Sry forward, 5-GCATTTATGGTGTGGTCCCGTG-3; and Sry reverse, 5-CC
AGTCTTGCCTGTATGTGATGG-3.
ES cell karyotype and immunostaining. Growing ES cells were treated with
Colticin (10 l/ml; Gibco) for 1 h. Cells were harvested, incubated for 18 min in
hypotonic solution (75 mM KCl), and subsequently fixed in fixative solution (1
volume of acetic acid in 3 volumes of methanol). Metaphases were allowed to dry
on slides overnight at 37°C and were stained with DAPI (4,6-diamidino-2-
phenylindole; Sigma). For immunostaining, ES cells were cultured in normal ES
cell medium on mitotically inactivated mouse embryonic fibroblasts (MEFs).
Cells were fixed for 10 min in 4% buffered formaldehyde and stained with the
antibodies indicated in the figure legends in the presence of 10% serum for 1 h
in a humid chamber.
Antibodies. Immunoblotting and immunostaining were performed with the
following antibodies: rabbit anti-Suz12, anti-H3K27me3, anti-H3K27me1 (where
me1 indicates monomethylation), anti-H3K9me3, anti-H3K9me2, and anti-
H3K4me2 from Upstate; rabbit anti -tubulin from Santa Cruz; rabbit anti-
H3K27me2 (33); mouse anti-EZH2 BD43 (32); mouse anti-H3K27me2/me3
(31); and rabbit anti-Nanog and rabbit anti-Oct4 from Abcam. Chromatin im-
munoprecipitation (ChIP) analysis was performed with the following antibodies:
rabbit anti-Suz12 and anti-H3K27me3 from Upstate, rabbit anti-polymerase II
and rabbit antihemagglutinin (Y11) from Santa Cruz, mouse monoclonal anti-
body to EZH2 (AC22) (32), mouse monoclonal antibody to BMI1 (AF27) (5),
and two rabbit affinity-purified polyclonal antibodies to CBX8 (hPc3), LAST and
GALD (5).
Gene expression analysis. Total RNA was extracted independently from three
Suz12/ (clones SBE 4, SBE5, and SBE6) and three Suz12/ (clones SBE1,
SBE7, and SBE8) ES cell clones. RNA was quantified, and equal amounts from
the three Suz12/ and the three Suz12/ samples were pooled into one sample
to reduce the experimental variation. Targets for microarray hybridization were
synthesized according to the supplier’s instructions (Affymetrix). Hybridization,
washing, staining, scanning, and data analysis were performed at the Affymetrix
microarray unit at the Institute of Molecular Oncology of the Italian Foundation
for Cancer Research-European Institute of Oncology campus, Milan, Italy, ac-
cording to the manufacturer’s instructions. Expression levels were analyzed using
Microarray Analysis Suite, version 5.0, statistical algorithm software (Af-
fymetrix), using the default parameters and scaling (TGT value) signal intensities
for all the GeneChip arrays to a value of 500. The Suz12/ samples were used
as a baseline condition for comparison with the Suz12/ samples.
Quantitative PCR and primers. cDNA preparation and real-time quantitative
PCR (qPCR) were performed following the manufacturer’s instructions (Ap-
plied Biosystems). The analysis of the results was performed as described pre-
viously (32). For primer sequences see Table S2 in the supplemental material.
EB formation and neuronal differentiation. Embryoid bodies (EBs) were
allowed to form in the absence of LIF in hanging drops containing 1,000 ES
cells/20-l drop on petri dish lids for 48 h. EBs were collected from the drops
after 2 days and left in culture in noncoated petri dishes for the times indicated
in the figure legends in ES medium in the absence of LIF. Medium was changed
every 2 days. Neuronal differentiation followed the above EB formation protocol
with the following modifications: EBs were treated from day 2 to day 5 with 0.5
M all-trans-retinoic acid (ATRA) and plated on gelatin-coated dishes at day 7
to allow neuronal differentiation. For ChIP analysis EBs were formed as mass
cultures by plating ES cells in suspension on noncoated petri dishes at the
concentration of 5  105 cells/ml.
ChIP. ChIP assays were performed as described previously (6).
Animal studies. Animal care and experiments on live animals were performed
at the University of Copenhagen in accordance with the Danish institutional and
national guidelines (law number 726, 9 September 1993), and the studies were
approved by the Dyreforsøgstilsynet committee (project number 2004/561-860).
RESULTS
Establishment of Suz12/ ES cells. To study the role of
Suz12 in ES cell proliferation, we attempted to derive ES cells
from the ICM of Suz12/ blastocysts. ICM outgrowths iso-
lated from blastocysts at E3.5 were expanded in tissue culture
in the presence of LIF. Genotypes of the individual clones
showed that both female and male Suz12/ ES cells could be
derived and maintained in culture (Fig. 1A). Suz12/ ES cells
do not display any morphological differences compared to
wild-type and Suz12/ cells (Fig. 1A and B, top panels).
Moreover, the proliferation rate of Suz12/ ES cells did not
differ significantly from wild-type and Suz12/ cells (data not
shown). Importantly, Suz12/ ES cells express normal levels
of the ES cell markers Oct4 and Nanog (Fig. 1C) and have a
normal karyotype (Fig. 1D). Consistent with the requirement
for Suz12 to stabilize Ezh2, Suz12/ ES cells have reduced
levels of Ezh2 (Fig. 1B). In order to further characterize the
Suz12/ ES cells, we stained for the expression of Oct4 and
Nanog. Consistent with the expression data presented in Fig.
1C, Suz12/ and Suz12/ ES cells but not feeder cells ex-
pressed high levels of both Oct4 and Nanog (Fig. 2A and B),
demonstrating that Suz12/ ES cells present normal ES cell
features.
Suz12 is required for di- and trimethylation of H3K27 in ES
cells. To determine if Suz12 is required for the methylation of
H3K27 in ES cells, we prepared cell lysates from proliferating
Suz12/ and Suz12/ ES cells. Remarkably, Suz12/ ES
cells have no detectable H3K27me3 and strongly reduced lev-
els of H3K27me2, whereas the methylation of other lysines on
the histone tails remains unchanged (Fig. 1E). These results
suggest that PRC2 is the major (if not the only) histone methyl
transferase responsible for H3K27me3 in ES cells. In addition,
they show that neither Suz12 nor of H3K27me is essential for
the self-renewal of ES cells.
Suz12/ ES cells express higher levels of differentiation-
specific genes. To further analyze the features of Suz12/ ES
cells, we compared the global gene expression profiles of
Suz12/ and Suz12/ ES cells using Affymetrix oligonucle-
otide microarrays containing probes for more than 39,000 dif-
ferent mouse transcripts. Significantly, Suz12/ ES cells con-
tain increased levels of differentiation-specific genes,
suggesting that Suz12/ ES cells have differentiated features,
despite displaying a normal stem cell phenotype (Fig. 3A). To
validate the gene expression data, we determined the expres-
sion levels for 25 upregulated and 5 downregulated genes in
Suz12/ and Suz12/ ES cells by real-time qPCR. As shown
in Fig. S1A in the supplemental material, the microarray data
were confirmed for all the tested genes, demonstrating the high
accuracy of the expression profile data. Because these genes
could be potential direct targets of the PRC2 complex, we
tested Ezh2 and Suz12 binding and the presence of H3K27me3
modification within a 3-kb promoter region upstream of the
transcription start site of the genes. ChIP analysis revealed that
10% (3/30) of the analyzed genes were direct targets of PRC2
(see Fig. S1 in the supplemental material) and that Ezh2 bind-
ing and accumulation of H3K27me3 at the Tbx3, Satb2, and
Otx2 promoters are dependent on Suz12 (see Fig. S1 in the
supplemental material). These results are consistent with the
requirement of Suz12 for Ezh2 enzymatic activity.
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In agreement with our results, Tbx3, Satb2, and Otx2 were
identified as direct PRC2 targets in whole genomic screenings
aimed at identifying PRC targets genes in ES cells (4, 21).
Surprisingly, several of the other PRC2 target genes identified
in previous studies were not identified as upregulated in
Suz12/ ES cells. One explanation for this could be that the
expression of these genes is not detectable in Suz12/ ES cells
by microarray technology, and they were therefore discarded in
the statistical analysis. To address this possibility, we compared
the expression of three differentiation-specific transcription
factors, Gata1, Gata4, and Hnf4, in Suz12/ and Suz12/ ES
cells. As shown in Fig. 3B, Gata1, Gata4, and Hnf4 expression
was indeed higher in the Suz12/ ES cells than in Suz12/
cells. Consistent with the repression by PRC2, the H3K27me3
repressive marker was present at the Gata1, Gata4, and Hnf4
promoters and lost in Suz12/ ES cells (Fig. 3B). These re-
sults are consistent with the model by which PRC2 represses
the expression of differentiation-specific genes in ES cells (4,
21) and demonstrate that Suz12 is required for this activity.
Interestingly, we also found that the expression of the pa-
ternally imprinted H19 gene is significantly increased in
Suz12/ ES cells relative to expression in to Suz12/ ES cells
(Fig. 3C; see also Table S1 and Fig. S1A in the supplemental
material). This result is consistent with the requirement of Eed
for the imprinting of different autosomal loci (24), suggesting
that imprinting could also be affected in Suz12/ embryos. To
understand if the PRC2 complex and H3K27me3 are directly
involved in the maintenance of H19 repression, we analyzed
the binding of Ezh2 and Suz12 and the presence of histone
H3K27me3 modification both at the H19 promoter (5 to 1
kb with respect to the transcription start site) and at the CG
regulatory element placed at the 3 end of the H19 locus. ChIP
FIG. 1. Analysis of Suz12/ ES cells. (A) Phase-contrast pictures of growing Suz12/ (clone SBE4) and Suz12/ (SBE8 8) ES cell clones
growing on feeders cells. (B) Phase-contrast pictures (top) of growing Suz12/ (clone SBE4) and Suz12/ (SBE1 and SBE8) ES cell clones on
gelatin-coated plates. Genotype and sex determination PCRs (middle) show that both male (M) and female (F) Suz12/ ES cells can be derived.
Immunoblots (bottom) using antibodies to Suz12, Ezh2, and -tubulin are shown. -Tubulin served as a loading control. KO, knockout; WT, wild
type. (C) RNA expression levels of the ES cell markers Oct4 and Nanog in Suz12/ and Suz12/ ES clones compared to MEFs. (D) Metaphase
spreads showing a normal karyotype for Suz12/ and Suz12/ ES clones. At the top the average numbers of counted chromosomes per cell are
given. The bottom panels are representative pictures of metaphase spreads from Suz12/ and Suz12/ ES clones. (E) Immunoblots of different
histone H3 lysine (K) modifications using specific antibodies to the indicated proteins and their modifications.
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analysis showed that neither PRC2 nor H3K27me3 was present
in the analyzed genomic regions (see Fig. S1A in the supple-
mental material), suggesting that either the PRC2 regulation is
indirect or that it involves the recruitment of PRC2 activity at
different sites or in earlier developmental stages.
Suz12 is required for differentiation of ES cells. Our findings
are consistent with the fact that Suz12/, Ezh2/, and
Eed/ embryos are all able to implant but fail to undergo
further development, and they suggest that PRC2 and its en-
zymatic activity are required for the differentiation processes
taking place during development. To investigate this, we took
advantage of the fact that ES cells undergo neuronal differen-
tiation in the presence of ATRA. Thus, we treated Suz12/
and Suz12/ ES cells with ATRA and found that while
Suz12/ ES cells efficiently form neurons, we were unable to
detect any neurons in ATRA-treated Suz12/ ES cells (Fig.
4A; see also Fig. S2A in the supplemental material). Consis-
tent with this, the expression of two neuron-specific markers,
GluR6 and Gad65, was strongly activated in Suz12/ differ-
entiated cells, but not in Suz12/ cells (Fig. 4B; see also Fig.
S2B in the supplemental material).
The differentiation of ES cells in tissue culture first requires
the formation of EBs, followed by terminal differentiation (18).
When ES cells are cultured in suspension in the absence of
LIF, they form EBs in which cells differentiate into the three
germ layers. EBs are the in vitro developmental equivalent of
the mouse embryo at the egg cylinder stage (E5.5 to E6). They
contain an outer endoderm layer and differentiating cells in the
center of the body, together with epithelial-like cavities. Be-
cause EBs represent the developmental stage when PRC2 mu-
tant embryos display morphological abnormalities and die, we
investigated whether EBs derived from Suz12/ ES cells
present any defects in differentiation. As shown in Fig. 4C and
Fig. S2C in the supplemental material, EBs from Suz12/
cells are morphologically normal, presenting an endodermal
outer layer and organized epithelial structures (Fig. 4C, left
frames). In contrast, Suz12/ EBs display a disorganized
structure and are often smaller. In addition, Suz12/ EBs fail
to form a proper endodermal layer and lack any form of in-
ternal organized structures (Fig. 4C, right frames; see also Fig.
S2C in the supplemental material). Consistent with the ability
of Suz12/ ES cells to form EBs in vitro, Suz12/ ES cells
were able to form teratomas when subcutaneously injected into
immunodeficient mice (data not shown).
To further support these results, we compared the expres-
sion of specific ES cell markers as well as the expression of
FIG. 2. Expression of Nanog and Oct4 in Suz12/ ES cells. Immunostaining of Suz12/ and Suz12/ ES cells growing on feeders cells shown
with anti-Nanog-specific (A) and anti-Oct4-specific (B) antibodies reveals expression of both ES cell markers in Suz12/ and Suz12/ ES cells
but not in feeder cells (arrows).
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genes specifically activated during gastrulation in Suz12/
and Suz12/ differentiating ES cells. Consistent with the lack
of germ layer formation, the expression of gastrulation-specific
genes (Brachyury, Pax3, Pax7, Fgf3, and Wnt3a) was activated
only in Suz12/ and not Suz12/ EBs (Fig. 5B). Moreover,
the expression of Oct4 and Nanog was fully repressed during
ES cell differentiation in Suz12/ ES cells, whereas the ex-
pression of the two stem cell transcription factors was only
partly repressed in Suz12/ EBs (Fig. 5A; see Fig. S2D in the
supplemental material), with expression levels approximately
FIG. 3. Suz12 is required for the regulation of a large number of genes involved in development, differentiation, and homeostasis. (A) Func-
tional clustering of gene expression changes between Suz12/ and Suz12/ ES cells. Expression downregulation refers to the functional
clustering of genes whose expression was downregulated in Suz12/ compared to Suz12/ ES cells. Expression upregulation refers to the
functional clustering of genes whose expression was upregulated in Suz12/ compared to Suz12/ ES cells. (B) Expression (top) and ChIP
analysis using the indicated antibodies (bottom) were determined by real-time qPCR. HA, hemagglutinin. (C) Expression levels of H19 in Suz12/
and Suz12/ male ES clones.
VOL. 27, 2007 Suz12 IS REQUIRED FOR ES CELL DIFFERENTIATION 3773
 o
n
 Septem
ber 4, 2018 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
50-fold higher in Suz12/ EBs at 9 days of differentiation
(Fig. 5A, right). Western blots presented in Fig. 5C further con-
firm this result and show that Oct4 and Nanog protein levels are
indeed still expressed in Suz12/ differentiated ES cells but not
in the control cells. Similar expression results were also obtained
for other genes like Fgf4, Fgf17, and Pou2F3 that are expressed in
ES cells and repressed upon differentiation (Fig. 4A).
In addition, due to the inability of Suz12/ ES cells to
terminally differentiate into neurons, we tested whether
Suz12/ ES cells are also impaired in the ability to differen-
tiate into early neuronal precursors. We analyzed the expres-
sion of the early neuronal markers Sox1, Nestin, Musashi, and
Calb2 during Suz12/ and Suz12/ ES cell differentiation.
Consistent with the lack of terminal differentiation, the activa-
tion of the expression of Sox1, Nestin, Musashi, and Calb2
during ES cell differentiation was observed in only Suz12/
and not Suz12/ ES cells. This result showed that Suz12/
ES cells are impaired in the proper activation of the expression
of neuronal precursor markers and suggest that the differen-
tiation defects of Suz12/ ES cells occur during the early
commitment phase of differentiation. Taken together, these
results demonstrate that Suz12 is required for ES cell differ-
entiation and that the lack of Suz12 results in both deregula-
tion of ES cell-specific genes and the inactivation of genes
required for early embryogenesis.
Mechanisms for PRC-mediated transcriptional regulation
during differentiation. Recently, we have identified genes tar-
geted by PRC2 and PRC1 in a human diploid fibroblast cell
line, TIG3 (5). Interestingly, the genes presented in Fig. 5A
and B were identified as direct targets of both PRCs in TIG3
cells, suggesting that the PRCs remain associated with the
promoters after their recruitment during early embryogenesis.
To determine if the binding of the PRCs is conserved between
human and mouse, we performed ChIP analysis in MEFs (see
Fig. S3A and B in the supplemental material). While Ezh2,
Suz12, and histone H3K27me3 were present on all promoters,
the PRC1 proteins Cbx8 and Bmi1 were not. Significant Cbx8
binding was detected at the Brachyury, Pax3, Pax7, Fgf4, and
Oct4 promoters, while significant Bmi1 binding was detected at
all promoters except for the Pou2f3. The differential binding
could be due to cell type differences and suggests that the
composition of PRC1 may differ from one cell type to another.
However, the results show that PRC2 binding at these genes is
fully conserved between mouse and human.
FIG. 4. Suz12/ ES cells fail to undergo proper differentiation. (A) Phase-contrast pictures of neuronal differentiation of Suz12/ and
Suz12/ ES cells. Arrows in the left panels show neuron formation in Suz12/ cells, while the right panels show lack of neuron formation in
Suz12/ cells. (B) Expression levels of two specific neuronal markers GluR6 and Gad65 showing strong activation in differentiated Suz12/ cells
and no activation in Suz12/ cells. Undiff, undifferentiated; diff, differentiated. (C) Hematoxylin and eosin staining of 7-day EBs formed by
Suz12/ and Suz12/ ES cells. Top panels show normal morphology of Suz12/ EBs. High-magnification fields highlight outer endodermal
layers and epithelium-like cavities. Bottom panels show Suz12/ EBs that lack forms of organized structures and that are often smaller.
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Interestingly, while Brachyury, Pax3, Pax7, Wnt3A, and Fgf3
are expressed at low levels in ES cells and become activated
upon differentiation (Fig. 4 and 5B), Fgf4, Pou2F3, Fgf17,
Nanog, and Oct4 are expressed in ES cells and become re-
pressed upon differentiation (Fig. 5A). Nanog and Oct4 are
essential transcription factors for ES cell self-renewal (17, 25)
and function both as activators and repressors of important
developmental regulators (3, 23). Pou2f3 is a member of the
Oct transcription factor family, but its biological role is poorly
characterized. Instead, Fgf4 and Fgf17 function as signaling
molecules that play a crucial role in the control of develop-
ment. Fgf4, for example, is required for the proliferation of
trophoblast stem cells (14).
To start addressing the mechanisms regulating the expres-
sion of the PcG target genes during early differentiation, we
analyzed the recruitment of Ezh2, Suz12, and H3K27me3 in
both Suz12/ and Suz12/ ES cells induced to undergo
differentiation. Surprisingly, we found that even though these
two groups of genes are inversely expressed during ES cell
differentiation (Fig. 5A and B), increased amounts of
H3K27me3 associate with all the promoters in a Suz12-depen-
dent manner during ES cell differentiation (Fig. 6 and 7A). In
fact, consistent with the requirement of Suz12 for Ezh2 his-
tone methyl transferase activity, Ezh2 binding and
H3K27me3 association were abolished in Suz12/ differ-
entiated ES cells (Fig. 6 and 7A). This result demonstrates
that increased association of histone H3K27me3 does not
prevent transcription and indicates that this modification
could have a role in transcriptional activation. Despite the
binding of PRC2 to the Oct4 and Nanog promoters in MEFs
(see Fig. S3 in the supplemental material), we were unable
to detect any significant PRC2 binding and H3K27me3 as-
sociation to these promoters during ES cell differentiation
(see Fig. S4 in the supplemental material), suggesting that
FIG. 5. Suz12/ ES cells fail to repress ES cells markers and to activate differentiation-specific genes upon induction of differentiation.
(A) Expression levels of Oct4, Nanog, Fgf4, Fgf17, and Pou2f3 in ES cells and in 9-day differentiated EBs determined by real-time qPCR. Right
panels highlight the expression differences between Suz12/ and Suz12/ in 9-day differentiated EBs. (B) Expression levels of gastrulation
markers in ES cells and in EBs at 3, 6, and 9 days after induction of differentiation. (C) Immunoblotting for Oct4 and Nanog during Suz12/ and
Suz12/ ES cell differentiation showing repression of Oct4 and Nanog expression in Suz12/ but not Suz12/ ES cells. (D) Expression levels
of Sox1, Nestin, Mausashi, and Calib2 during Suz12/ and Suz12/ ES cell differentiation showing the lack of activation of the neuronal precursor
marker in Suz12/ cells.
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PRC2 indirectly regulates these promoters during the early
events of ES cell differentiation.
To understand if PRC1 is also recruited to these PRC2
target promoters, we analyzed the binding of two subunits of
PRC1, Cbx8 and Bmi1, in Suz12/ and Suz12/ ES cells.
Consistent with the idea that both PRC1 and PRC2 are re-
quired for the regulation of the expression of common targets
(4, 5, 21), we found that five of these promoters (Brachyury,
Pax3, Pax7, Fgf3, and Fgf4) showed significant binding of Cbx8
in differentiated EBs, while only one promoter (Pax7) showed
binding of Bmi1 (Fig. 6 and 7A). However, in contrast to the
model that has PRC1 recruitment dependent on its ability to
specifically bind H3K27me3 (7, 8, 19), we found that PRC1
recruitment is independent of H3K27me3 on three of the five
Cbx8 targets (Pax7, Fgf3, and Fgf4) and on the Bmi1 target
(Pax7). This result, demonstrates that PRC1 can be recruited
to target genes in the absence of a functional PRC2 complex
and independently of H3K27me3.
Interestingly, Cbx8 and Bmi1 are not present on PcG target
genes in nondifferentiated ES cells (Fig. 6 and 7A and data not
shown). To obtain a potential explanation for this, we prepared
cell lysates from Suz12/ and Suz12/ ES cells at different
stages of differentiation, and from proliferating (passage 3
[P3]) and senescent (P7) MEFs (Fig. 5B). Remarkably, Cbx8 is
not detectably expressed in undifferentiated ES cells but accu-
mulates during differentiation (Fig. 7B). Interestingly, Cbx8
expression is not fully induced in Suz12/ differentiated ES
cells, which could be a result of the lack of proper differenti-
ation of these cells. Unlike Cbx8, Bmi1 is expressed in ES cells
and further accumulates 3 days after induction of differentia-
tion. However, since Bmi1 is not recruited to PRC1 target
genes in nondifferentiated cells, this may suggest that Bmi1
recruitment is dependent on Cbx8 expression. In addition,
slower-migrating forms, which might result from phosphoryla-
tions, as suggested by previously published findings, (35), ap-
pear during the differentiation of the ES cells with kinetics
similar to Cbx8 accumulation. These forms become prominent
in MEFs, which may suggest that posttranslation modifications
of Bmi1 could be a regulatory mechanism for the recruitment
of PRC1 to target genes.
DISCUSSION
The development of the mammalian organism requires the
specification of more than 200 different cell types in a process
that takes place prior to and immediately after the implanta-
tion of the embryo. Cell type specification is controlled by
gradients of tissue-specific transcription factors in concert with
a host of epigenetic regulators. Histone modifying enzymes,
like the PRCs, are believed to play a critical role in this pro-
FIG. 6. PcG binding does not prevent transcriptional activation. ChIP analyses performed on promoters of genes that are activated during
differentiation of ES cells. Real-time qPCR was used to determine the expression levels of the genes, and values were normalized as described in
Materials and Methods. Antibodies specific for Ezh2, Suz12, Cbx8, Bmi1, H3K27me3, and the hemagglutinin (HA) epitope (negative control) were
used for ChIPs. Enrichment is given as a percentage of input. Black bars, Suz12/ cells; red bars, Suz12/ cells; d, day; Ab, antibody.
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FIG. 7. PRC2 is actively recruited to repress gene transcription during ES cell differentiation. (A) ChIP analysis of the promoter regions of
repressed genes during ES cell differentiation using antibodies against Ezh2, Suz12, Cbx8, Bmi1, and histone H3K27me3. Results of ChIPs and
qPRCs in Suz12/ (black bars) and Suz12/ ES cells (red bars) are shown. The expression profile for each gene during differentiation is also
presented (far left). HA, hemagglutinin; Ab, antibody. (B) Immunoblots of Suz12, Ezh2, Eed, Cbx8, and Bmi1 in Suz12/ and Suz12/ ES cells
and in proliferating (P3) and senescent (P7) MEFs. -Tubulin served as a loading control. (C) Different models for how the PcG proteins regulate
transcription during differentiation. In the derepression model (1) the PcGs repress the expression of differentiation-specific genes in proliferating
ES cells. The loss of PcG binding during differentiation leads to the activation or derepression of transcription. In the repression model (2) the
PcGs are specifically recruited to target genes that undergo transcriptional repression during differentiation. In the activation model (3) PcGs
(PRC2) accumulate on a subset of target genes during differentiation despite their transcriptional activation. In this model we propose that the
binding of transcriptional activators is sufficient to overcome the PcGs. The binding of the PcGs could be important for the repression of the target
genes during terminal differentiation and in this way preprogram the target genes during early development.
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cess. PRC2 is required for correct expression of the HOX genes
in later development (1, 20, 34), but defects in embryos lacking
functional PRC2 arise earlier than HOX expression, suggesting
additional functions of the complex (16, 30, 32).
In this work we have shown that even though Suz12/ ES
cells proliferate and appear normal, their ability to undergo
proper differentiation is compromised. We provide evidence
that this is due to the failure to establish the correct transcrip-
tion programs during early embryogenesis. This assumption is
in agreement both with the fact that Suz12/ and Eed mutant
ES cells expression patterns are altered toward a more differ-
entiated phenotype and with the finding that Ezh2 activity is
required for correct development before the four-cell stage
during embryogenesis (4, 13). Similarly to Suz12/ ES cells,
Eed mutant ES cells can be maintained in culture, and, despite
their tendency to differentiate (4), they can efficiently form EBs
in vitro and contribute to gastrulation in vivo in chimeric em-
bryos (27). Interestingly, the fact that Ezh2 (30), but not Eed
and Suz12, is required for ES cell proliferation indicates that
Ezh2 has additional functions independent of H3K27 methyl-
ation. This notion is supported by data obtained in Drosophila,
where mutants of the Ezh2 homologue E(z) have additional
phenotypic defects to those observed in Esc (dEed) and
Su(z)12 (dSuz12) mutant flies (1, 20, 34).
The effects of the lack of PRC2 transcriptional control are
more evident when Suz12/ ES cells are induced to differen-
tiate. We found that Suz12 is required for proper ES cell
differentiation. Key developmental transcription factors such
as Brachyury, Pax3, and Pax7 as well as early neuronal markers
such as Sox1, Nestin, Musashi, and Calb2 are not activated by
differentiation signals in the absence of Suz12. Moreover, dur-
ing differentiation Suz12 appears to be required for the repres-
sion of genes essential for ES cell self-renewal, such as Nanog
and Oct4. This could be a consequence of the differentiation
failure of the Suz12/ ES cells, but since ectopic expression of
Nanog can block ES cell differentiation in vitro (11), sustained
Nanog expression in the Suz12/ ES cells could also contrib-
ute to the impairment of proper differentiation of the Suz12/
ES cells. Our results showing that PcGs bind directly to the
Nanog and Oct4 promoters in MEFs and that they are associ-
ated with H3K27me3 support the notion that the expression of
these promoters is controlled by the PcGs. In any event, it
would be extremely interesting to know if the differentiation
defects of Suz12/ ES cells depend on lack of Nanog and/or
Oct4 repression; however, this experiment is unfortunately not
feasible because ES cells do not grow in the absence of the two
transcription factors (25, 29).
Our results demonstrating the accumulation of the PRCs
and H3K27me3 on promoters for differentiation-induced
genes is very exciting and support our previous findings that
PcG-binding and H3K27me3 accumulation might not be suf-
ficient to prevent transcription (5). In our previous work (5),
we proposed that PcG binding to active promoters in progen-
itor cells preprograms these genes for repression during ter-
minal differentiation. Here, we have provided evidence that
the PcGs are indeed specifically recruited to active promoters
in progenitor cells. Moreover, our results could further suggest
that the recruitment of the PcGs to these target genes may be
required for their transcriptional activation.
In addition to demonstrating the essential role of Suz12 in
ES cell differentiation, our analysis of PcG target genes sug-
gests a number of mechanisms by which the PcGs control
transcription. So far the only mechanism that is backed up by
experimental data is outlined in the derepression model (Fig.
7C, model 1). This model involves the dissociation of PcG
proteins upon induction of differentiation and allows activation
of target genes and subsequent differentiation. Several exper-
imental results using myoblasts (10), ES cells (4, 21), and
NTera2 cells (5) support this model. ChIP analysis presented
in this work further supports the derepression model showing
that differentiation-specific genes are indeed repressed by the
PcGs in Suz12/ ES cells and that this repressive activity is
lost in Suz12/ ES cells.
In this study, we have shown that the PcGs are also actively
recruited to target genes upon induction of differentiation.
Surprisingly, we found that this recruitment can correlate with
either transcriptional repression or activation of genes during
differentiation.
In the first case, we found that differentiation signals lead to
recruitment of PRC2 to target genes and that this recruitment
correlates with repression of transcription. Importantly, this
repression is dependent on Suz12, suggesting that direct bind-
ing of PRC2 plays a critical role in the repression of these
genes. Based on these results we propose a mechanism, sum-
marized in the repression model presented in Fig. 7C, whereby
the PcGs regulate transcription of specific target genes during
differentiation. If this model is accurate, the identification of
the signaling pathways and the factors that trigger the specific
recruitment of the PRCs will be important for understanding
how differentiation is regulated.
In the second case, we found increased levels of PRC2 on
the promoters of genes activated during differentiation. Since
PRC2 is believed to function as a repressor of transcription,
this is an intriguing result. Furthermore, the striking observa-
tion that the genes were not activated in Suz12/ ES cells, i.e.,
in the absence of PRC2 recruitment, could suggest that PRC2
has a direct role in the transcriptional activation of these tar-
gets. However, it is important to stress that the lack of tran-
scriptional activation could be a consequence of the failure of
Suz12/ ES cells to undergo proper differentiation. In this
case, the early recruitment of the PRCs could simply epige-
netically predispose these genes for later repression. A model
for how PcGs may participate in the activation of target genes
is depicted in Fig. 7C.
In conclusion, our results and those from other laboratories
demonstrate that Suz12 and PRC2 are required for ES cell
differentiation, most likely by directly controlling specific gene
expression during cellular commitment. ES cells become an
attractive tool for regenerative therapy due to their in vitro
differentiation potential. Embryo cloning by somatic cell nu-
clear transfer (SCNT) could give important therapeutic advan-
tages as a source of ES-like cells that can be in vitro differen-
tiated and used for autologous implants. Low efficiency in
therapeutic cloning is the major obstacle to overcome because
epigenetic commitment of somatic cells is a major problem in
successful embryo cloning. The failure to achieve correct re-
activation of genes like Nanog and Oct4 has been linked to the
failure of embryos obtained by SCNT to implant and success-
fully develop. Manipulation of PRC2 activity could therefore
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contribute to the reprogramming of somatic cells and increase
the efficiency of successful SCNT embryo cloning.
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